Mako robotic arm technology is transforming the experience of patients undergoing joint replacement surgery all around the world.
The impacts of lockdown are being felt in many different ways but one of these is in weight gain among certain sectors of the population. If you are due to undergo joint replacement surgery this could have a detrimental impact on the outcomes of your surgery.
As we approach the end of 2020, this seems a good moment to pause and reflect on this extraordinary year and everything we have learned. I doubt that any of us would have predicted quite what a challenging year this was going to be and how much our everyday life would be disrupted by the…
Andrew Carrothers Features in Acclaimed TV Series Performing Pioneering Treatment Founder of Carrothers Orthopaedics, Andrew Carrothers showcased his extraordinary surgical skills in the new BBC series of Surgeons: At The Edge of Life. He was performing a combination of operations for cancer patients to help restore mobility. The highly acclaimed BBC series, which features the pioneering…
About Arthritis – did you know?
An innovative robotic arm called Mako is revolutionising total hip replacement surgery, leading to reduced pain and likely long-term better outcomes for patients.
Living with chronic hip pain can have a huge impact on your quality of life. Your hips are vital for standing, sitting, walking and running so constant pain can make everyday life and activities extremely challenging.
A robot called MAKO is helping orthopaedic surgeons to perform personalised joint replacement surgery, achieving better results and faster recovery rates than ever before.
At the start of a new year, many of us feel the urge to take control of our lives in one way or another. If you suffer from chronic arthritis you may have more reasons than most to want to act.
3D printing is already being used to create customised orthopaedic implants for joint replacement surgery. Now, further technological advances are offering a glimpse into the future of orthopaedics whereby synthetic implants could be populated with a patient’s own cells to encourage tissue regeneration.